58
Participants
Start Date
May 31, 2008
Primary Completion Date
November 30, 2011
Study Completion Date
October 31, 2013
Temozolomide
Taken orally daily for the first three weeks of a four-week cycle.
University Of Pennsylvania, Philadelphia
Wake Forest Univsersity, Winston-Salem
Tufts Medical Center, Boston
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Dartmouth-Hitchcock Medical Center, Lebanon
Collaborators (1)
Brigham and Women's Hospital
OTHER
Massachusetts General Hospital
OTHER
University of Pennsylvania
OTHER
Wake Forest University Health Sciences
OTHER
Tufts Medical Center
OTHER
Dartmouth-Hitchcock Medical Center
OTHER
Schering-Plough
INDUSTRY
Patrick Y. Wen, MD
OTHER